George Kemble insider trades

Open-market stock purchases and sales by George Kemble, Director at Sagimet Biosciences Inc, from SEC Form 4 filings since Jul 18, 2023.

Recent trades

DateStockTradeValue
Jun 12, 2026SGMT Sagimet Biosciences IncBought (not open market)—
Nov 20, 2025SGMT Sagimet Biosciences IncSold$290K

Companies traded

  • SGMT Sagimet Biosciences Inc: 3 sales, last Jun 12, 2026

Get free alerts when George Kemble files a new trade →